Granite Group Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Granite Group Advisors's AMGN Position: Q3 2026 in Review
Granite Group Advisors reduced its Amgen (AMGN) stake by 32% in Q3 2026, selling an estimated $1.12M and leaving 5,936 shares worth $2.5M. The position accounts for 1.58% of the portfolio, ranked #12.
Granite Group Advisors first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.17M in Q2 2026. 3,022 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Granite Group Advisors held 5,936 shares of Amgen worth $2.5M as of Q3 2026.
- Granite Group Advisors sold 2,818 Amgen shares in Q3 2026, an estimated $1.12M.
- Amgen made up 1.58% of Granite Group Advisors's portfolio in Q3 2026, its #12 holding.
- Granite Group Advisors first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
- Granite Group Advisors's Amgen position peaked at $3.17M in Q2 2026.
- 3,022 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Granite Group Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.